Proshares UltraPro Nasdaq Biotechnology (UBIO) dropped -6.42% or -2.13 to $31.06. It is near to 84034 shares traded, which is 141.43% compare to the average total volume 59419. The market cap of UBIO is $32.61 million. The year to date change is -14.53%. The 52 week price range is from $25.8 to $46.35. Price of UBIO have changed -10.51% during last week. It have changed 7.03% over last month, -0.15% over last 3 months, -3.15% over last 6 months and -5.17% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBIO is 31.36. It is 0.97% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for UBIO is 34.41. It is 10.79% above current price. The 52-week High is 46.35. It is 49.23% from the current price. The 52-week Low is 25.8. It is -16.93% from current price.
There are some statistics of UBIO. It is has market cap $32.61 million. The share outstanding is 1.10 million. The average volume is 59419. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBIO is 1.43%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBIO is -6.17%.